189 related articles for article (PubMed ID: 32382759)
41. Hyperinsulinemia in african-american children: decreased insulin clearance and increased insulin secretion and its relationship to insulin sensitivity.
Arslanian SA; Saad R; Lewy V; Danadian K; Janosky J
Diabetes; 2002 Oct; 51(10):3014-9. PubMed ID: 12351441
[TBL] [Abstract][Full Text] [Related]
42. Intact proinsulin, des 31,32 proinsulin, and specific insulin concentrations among nondiabetic and diabetic subjects in populations at varying risk of type 2 diabetes.
Nagi DK; Knowler WC; Mohamed-Ali V; Bennett PH; Yudkin JS
Diabetes Care; 1998 Jan; 21(1):127-33. PubMed ID: 9538983
[TBL] [Abstract][Full Text] [Related]
43. Hyperinsulinemia in African-American adolescents compared with their American white peers despite similar insulin sensitivity: a reflection of upregulated beta-cell function?
Hannon TS; Bacha F; Lin Y; Arslanian SA
Diabetes Care; 2008 Jul; 31(7):1445-7. PubMed ID: 18417751
[TBL] [Abstract][Full Text] [Related]
44. Impaired Suppression of Glucagon in Obese Subjects Parallels Decline in Insulin Sensitivity and Beta-Cell Function.
Chen X; Maldonado E; DeFronzo RA; Tripathy D
J Clin Endocrinol Metab; 2021 Apr; 106(5):1398-1409. PubMed ID: 33524152
[TBL] [Abstract][Full Text] [Related]
45. Impaired beta-cell and alpha-cell function in African-American children with type 2 diabetes mellitus--"Flatbush diabetes".
Banerji MA
J Pediatr Endocrinol Metab; 2002 Apr; 15 Suppl 1():493-501. PubMed ID: 12017222
[TBL] [Abstract][Full Text] [Related]
46. Racial and ethnic differences in the metabolic response of polycystic ovary syndrome.
Ezeh U; Ida Chen YD; Azziz R
Clin Endocrinol (Oxf); 2020 Aug; 93(2):163-172. PubMed ID: 32286715
[TBL] [Abstract][Full Text] [Related]
47. Gender differences in cardiovascular risk factors in obese, nondiabetic first degree relatives of African Americans with type 2 diabetes mellitus.
Gaillard TR; Schuster DP; Osei K
Ethn Dis; 1998; 8(3):319-30. PubMed ID: 9926902
[TBL] [Abstract][Full Text] [Related]
48. Racial differences in insulin resistance and mid-thigh fat deposition in postmenopausal women.
Ryan AS; Nicklas BJ; Berman DM
Obes Res; 2002 May; 10(5):336-44. PubMed ID: 12006632
[TBL] [Abstract][Full Text] [Related]
49. Influence of hyperinsulinemia and insulin resistance on in vivo β-cell function: their role in human β-cell dysfunction.
Mari A; Tura A; Natali A; Anderwald C; Balkau B; Lalic N; Walker M; Ferrannini E;
Diabetes; 2011 Dec; 60(12):3141-7. PubMed ID: 22028180
[TBL] [Abstract][Full Text] [Related]
50. A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes.
Kashyap S; Belfort R; Gastaldelli A; Pratipanawatr T; Berria R; Pratipanawatr W; Bajaj M; Mandarino L; DeFronzo R; Cusi K
Diabetes; 2003 Oct; 52(10):2461-74. PubMed ID: 14514628
[TBL] [Abstract][Full Text] [Related]
51. Insulin sensitivity differs among ethnic groups with a compensatory response in beta-cell function.
Chiu KC; Cohan P; Lee NP; Chuang LM
Diabetes Care; 2000 Sep; 23(9):1353-8. PubMed ID: 10977032
[TBL] [Abstract][Full Text] [Related]
52. Impaired fasting glucose with or without impaired glucose tolerance: progressive or parallel states of prediabetes?
Perreault L; Bergman BC; Playdon MC; Dalla Man C; Cobelli C; Eckel RH
Am J Physiol Endocrinol Metab; 2008 Aug; 295(2):E428-35. PubMed ID: 18523123
[TBL] [Abstract][Full Text] [Related]
53. Epinephrine exerts opposite effects on peripheral glucose disposal and glucose-stimulated insulin secretion. A stable label intravenous glucose tolerance test minimal model study.
Avogaro A; Toffolo G; Valerio A; Cobelli C
Diabetes; 1996 Oct; 45(10):1373-8. PubMed ID: 8826974
[TBL] [Abstract][Full Text] [Related]
54. Primary defects in beta-cell function further exacerbated by worsening of insulin resistance mark the development of impaired glucose tolerance in obese adolescents.
Cali AM; Man CD; Cobelli C; Dziura J; Seyal A; Shaw M; Allen K; Chen S; Caprio S
Diabetes Care; 2009 Mar; 32(3):456-61. PubMed ID: 19106382
[TBL] [Abstract][Full Text] [Related]
55. Indices of insulin action, disposal, and secretion derived from fasting samples and clamps in normal glucose-tolerant black and white children.
Uwaifo GI; Fallon EM; Chin J; Elberg J; Parikh SJ; Yanovski JA
Diabetes Care; 2002 Nov; 25(11):2081-7. PubMed ID: 12401760
[TBL] [Abstract][Full Text] [Related]
56. Five-Year Glycemic Trajectories Among Healthy African-American and European-American Offspring of Parents With Type 2 Diabetes.
Razavi LN; Ebenibo S; Edeoga C; Wan J; Dagogo-Jack S
Am J Med Sci; 2020 May; 359(5):266-270. PubMed ID: 32359533
[TBL] [Abstract][Full Text] [Related]
57. Glucoregulatory function among African Americans and European Americans with normal or pre-diabetic hemoglobin A1c levels.
Ebenibo S; Edeoga C; Wan J; Dagogo-Jack S
Metabolism; 2014 Jun; 63(6):767-72. PubMed ID: 24641885
[TBL] [Abstract][Full Text] [Related]
58. Postprandial serum C-peptide to plasma glucose concentration ratio correlates with oral glucose tolerance test- and glucose clamp-based disposition indexes.
Okuno Y; Komada H; Sakaguchi K; Nakamura T; Hashimoto N; Hirota Y; Ogawa W; Seino S
Metabolism; 2013 Oct; 62(10):1470-6. PubMed ID: 23831440
[TBL] [Abstract][Full Text] [Related]
59. Impaired insulin sensitivity, insulin secretion, and glucose effectiveness predict future development of impaired glucose tolerance and type 2 diabetes in pre-diabetic African Americans: implications for primary diabetes prevention.
Osei K; Rhinesmith S; Gaillard T; Schuster D
Diabetes Care; 2004 Jun; 27(6):1439-46. PubMed ID: 15161801
[TBL] [Abstract][Full Text] [Related]
60. Correlation of oral glucose tolerance test-derived estimates of insulin sensitivity with insulin clamp measurements in an African-American cohort.
Cheng C; Campbell KL; Kushner H; Falkner BE
Metabolism; 2004 Sep; 53(9):1107-12. PubMed ID: 15334368
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]